Connection

James Ballenger to Treatment Outcome

Back to Details
This is a "connection" page, showing publications James Ballenger has written about Treatment Outcome.
James Ballenger
Connection Strength
0.454
Treatment Outcome
  1. A pilot study of vagus nerve stimulation (VNS) for treatment-resistant anxiety disorders. Brain Stimul. 2008 Apr; 1(2):112-21.
    View in: PubMed
    Score: 0.032
  2. Remission rates in patients with anxiety disorders treated with paroxetine. J Clin Psychiatry. 2004 Dec; 65(12):1696-707.
    View in: PubMed
    Score: 0.026
  3. Personality and symptom sensitivity predictors of alprazolam withdrawal in panic disorder. Psychol Med. 2003 Apr; 33(3):511-8.
    View in: PubMed
    Score: 0.023
  4. Consensus statement on generalized anxiety disorder from the International Consensus Group on Depression and Anxiety. J Clin Psychiatry. 2001; 62 Suppl 11:53-8.
    View in: PubMed
    Score: 0.020
  5. Treatment of anxiety disorders to remission. J Clin Psychiatry. 2001; 62 Suppl 12:5-9.
    View in: PubMed
    Score: 0.020
  6. Procedural and methodological issues in telepsychiatry research and program development. Psychiatr Serv. 2000 Dec; 51(12):1522-7.
    View in: PubMed
    Score: 0.020
  7. Structural issues and policy in the management of depressive illness. Overview and expert panel commentary. Eur Neuropsychopharmacol. 2000 Dec; 10 Suppl 4:S449-53.
    View in: PubMed
    Score: 0.020
  8. A controlled trial of daily left prefrontal cortex TMS for treating depression. Biol Psychiatry. 2000 Nov 15; 48(10):962-70.
    View in: PubMed
    Score: 0.019
  9. Recognizing the patient with social anxiety disorder. Int Clin Psychopharmacol. 2000 Jul; 15 Suppl 1:S1-5.
    View in: PubMed
    Score: 0.019
  10. Vagus nerve stimulation: a new tool for brain research and therapy. Biol Psychiatry. 2000 Feb 15; 47(4):287-95.
    View in: PubMed
    Score: 0.018
  11. Consensus statement on posttraumatic stress disorder from the International Consensus Group on Depression and Anxiety. J Clin Psychiatry. 2000; 61 Suppl 5:60-6.
    View in: PubMed
    Score: 0.018
  12. Consensus statement on the primary care management of depression from the International Consensus Group on Depression and Anxiety. J Clin Psychiatry. 1999; 60 Suppl 7:54-61.
    View in: PubMed
    Score: 0.017
  13. Clinical guidelines for establishing remission in patients with depression and anxiety. J Clin Psychiatry. 1999; 60 Suppl 22:29-34.
    View in: PubMed
    Score: 0.017
  14. Sleep Deprivation in social phobia and generalized anxiety disorder. Biol Psychiatry. 1998 Jun 01; 43(11):840-2.
    View in: PubMed
    Score: 0.016
  15. Comorbidity of panic and depression: implications for clinical management. Int Clin Psychopharmacol. 1998 Apr; 13 Suppl 4:S13-7.
    View in: PubMed
    Score: 0.016
  16. Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorder. Am J Psychiatry. 1998 Jan; 155(1):36-42.
    View in: PubMed
    Score: 0.016
  17. Consensus statement on panic disorder from the International Consensus Group on Depression and Anxiety. J Clin Psychiatry. 1998; 59 Suppl 8:47-54.
    View in: PubMed
    Score: 0.016
  18. Consensus statement on social anxiety disorder from the International Consensus Group on Depression and Anxiety. J Clin Psychiatry. 1998; 59 Suppl 17:54-60.
    View in: PubMed
    Score: 0.016
  19. Sleep deprivation in panic disorder and obsessive-compulsive disorder. Can J Psychiatry. 1997 Nov; 42(9):982-3.
    View in: PubMed
    Score: 0.016
  20. Recent developments in the psychopharmacology of anxiety disorders. J Consult Clin Psychol. 1996 Aug; 64(4):660-8.
    View in: PubMed
    Score: 0.014
  21. Clinical evaluation of venlafaxine. J Clin Psychopharmacol. 1996 Jun; 16(3 Suppl 2):29S-35S; discussion 35S-36S.
    View in: PubMed
    Score: 0.014
  22. Sertraline in social phobia. J Clin Psychopharmacol. 1995 Oct; 15(5):372-3.
    View in: PubMed
    Score: 0.014
  23. Valproate in the treatment of acute bipolar affective episodes complicated by substance abuse: a pilot study. J Clin Psychiatry. 1995 Mar; 56(3):118-21.
    View in: PubMed
    Score: 0.013
  24. Panic disorder: efficacy of current treatments. Psychopharmacol Bull. 1993; 29(4):477-86.
    View in: PubMed
    Score: 0.011
  25. Vagus nerve stimulation. A potential therapy for resistant depression? Psychiatr Clin North Am. 2000 Dec; 23(4):757-83.
    View in: PubMed
    Score: 0.005
  26. Bupropion-SR in treatment of social phobia. Depress Anxiety. 2000; 12(2):111-3.
    View in: PubMed
    Score: 0.005
  27. A double-blind evaluation of the safety and efficacy of abecarnil, alprazolam, and placebo in outpatients with generalized anxiety disorder. Abecarnil Work Group. J Clin Psychiatry. 1997; 58 Suppl 11:11-8.
    View in: PubMed
    Score: 0.004
  28. Long-term follow-up after a drug trial for panic disorder. Br J Psychiatry. 1995 Oct; 167(4):487-94.
    View in: PubMed
    Score: 0.003
  29. A placebo-controlled trial of L-365,260, a CCKB antagonist, in panic disorder. Biol Psychiatry. 1995 Apr 01; 37(7):462-6.
    View in: PubMed
    Score: 0.003
  30. Alprazolam plasma concentrations and treatment response in panic disorder and agoraphobia. Am J Psychiatry. 1992 Nov; 149(11):1556-62.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.